Endoscopic Pilonidal Sinus Treatment (EPSIT) Experience of a Provincial Hospital in Eastern Turkey
Journal Title: Turkish Journal of Colorectal Disease - Year 2020, Vol 30, Issue 3
Abstract
Aim: Pilonidal sinus (PS) is an inflammatory disease of the sacrococcygeal region that negatively affects the life of the individual. Although there are many treatment modalities for the disease, a gold standard treatment method has not yet been determined. It was aimed to compare the endoscopic PS treatment method with other treatment methods in pediatric patients treated for PS in a second-line provincial hospital. Method: After obtaining approval from Erzurum Regional Training and Research Hospital Ethics Committee with the decision number 2020/06-66, pediatric patients under 18 years of age who were operated for PS in Muş Provincial Hospital between January 2017 and January 2020 were retrospectively analyzed. Patients were operated in the prone position, under spinal anesthesia by using total excision + primary closure, total excision + limberg flap, and endoscopic PS treatment (EPSIT) + phenol application methods. Patients’ age, gender, length of hospital stay, time to return to work or school, and minor and major complications were analyzed. Results: Forty eight patients in pediatric age group were included in the study. The average age of the patients was 16,18 years; 20 (41.6%) of the patients were male and 28 (58.3%) were female. The hospitalization period was 3,48 days and the average follow-up period was 480 days (16 months). Time to return to work was 10,6 (3-28) days. Forty eight patients underwent surgery. Limberg flap method was used in 13, primary closure method in 9 and EPSIT method in 26 patients. Six patients had recurrence, 5 patients developed minor complications such as seroma and necrotic fat tissue. The hospitalization period was 2 days and the time to return to work was 4.46 days in patients who underwent the EPSIT method, which was superior to the other two methods. The biggest disadvantage of the EPSIT method was the recurrence rate (n=4 patients, 15.3%). Conclusion: Although the recurrence rate of the EPSIT method with phenol application is high, it is more advantageous than other methods due to the short time to return to work or school and shorter hospital stay.
Authors and Affiliations
Rıfat Peksöz, Mehmet Can
Keywords
Related Articles
- EP ID EP688615
- DOI 10.4274/tjcd.galenos.2020.2020-3-8
- Views 157
- Downloads 0
Seton Application in Complex Perianal Fistula: Video Presentation
Anal fistulas are non-physiological tract-like structures that open into the perianal skin starting from the distal rectum or anal canal and arise from abscesses on the basis of infection in the rudimentary glands around...
In Patients with Recurrent Pilonidal Sinus, Should the First Approach be Crystallised Phenol or Limberg Flap?
Aim: In our study, we aimed to compare the efficacy of Limberg flap and crystallised phenol treatments applied to patients with recurrent pilonidal sinus. Method: Patients with recurrent pilonidal sinus disease who were...
Predictive Value of Red Cell Distribution Width and Mean Platelet Volume in the Diagnosis and Determination of Severity in Acute Appendicitis Cases
Aim: We aimed to determine the clinical value of erythrocyte distribution width (RDW) and mean platelet volume (MPV) in the diagnosis of acute appendicitis (AA) and in determining the severity of the disease. Method: Pa...
Does a Distal Surgical Margin Closer than 10 mm Increase the Risk of Recurrence in Locally Advanced Rectal Cancer in a Mid-Distal Location?
Aim: Although many factors affecting recurrence, including surgical margin involvement, have been considered in rectum cancer surgery, there is no consensus on the definition of a safe distal surgical margin (DSM).We aim...
Use of Endo-GIA Stapler in Transanal Mass Excision: Case Report
Rectal cancers comprise approximately 1/3 of colorectal cancers. Tumors tha treach the submucosa on the rectum wall but do not overcome the submucosa are called early rectal cancers. T1 and T2 early-stage rectal cancers...